Phospholipase A2-IVA (PLA2G4A) not only plays a vital role in the development of various solid tumours [27,28], but was also illustrated to independently predict OS in patients with non-M3/NPM1 WT AML [29]. This evidence concerns the gene NPM1 and acute myeloid leukemia.